Durable responses to immune checkpoint blockade (ICB) depends not only on activating T cells, but also on reestablishing communication between immune cell populations that work together to eliminate tumors. The post Broader Immune Targeting Increases Immunotherapy Benefit in Colorectal Cancer appeared first on Inside Precision Medicine .